SCHEMBL7001583

SCHEMBL7001583

CCCn1c(=O)c2[nH]c(C)nc2n2nc(Cc3ccccc3)nc12

nearest known ligand 0.57

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 3/20 0.49
ADORA2B P29275 2/20 0.49
KDM4E B2RXH2 1/20 0.46
MEN1 O00255 1/20 0.46
ALDH1A1 P00352 1/20 0.46
CYP1A2 P05177 1/20 0.46
CYP3A4 P08684 1/20 0.46
CYP2C9 P11712 1/20 0.46
CYP2C19 P33261 1/20 0.46
KMT2A Q03164 1/20 0.46
HSD17B10 Q99714 1/20 0.46
ADORA3 P0DMS8 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6999142 0.83 SIRT1 (0.46) ADORA2AADORA2BKDM4EMEN1ALDH1A1
SCHEMBL7661252 0.82 ADORA1 (0.47) ADORA2AADORA2BKDM4EMEN1ALDH1A1
SCHEMBL7656833 0.81 KMT2A (0.50) ADORA2AADORA2BKDM4EMEN1ALDH1A1
SCHEMBL7657404 0.81 TSHR (0.46) ADORA2AADORA2BKDM4EMEN1ALDH1A1
SCHEMBL7670431 0.77 ADORA2B (0.54) ADORA2AADORA2BKDM4EMEN1ALDH1A1
SCHEMBL8560750 0.76 PDE4A (0.52) ADORA2AADORA2BHSD17B10ADORA3
SCHEMBL6995974 0.76 MEN1 (0.49) ADORA2AADORA2BMEN1CYP1A2CYP3A4
SCHEMBL8560002 0.75 ADORA1 (0.58) ADORA2AADORA2BKDM4EMEN1ALDH1A1
SCHEMBL7659412 0.74 ADORA2B (0.45) ADORA2AADORA2BKDM4EMEN1ALDH1A1
SCHEMBL7668670 0.73 ADORA2B (0.51) ADORA2AADORA2BKDM4EMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1087973-B1 IMIDAZOTRIAZOLOPYRIMIDINES USED AS A DRUG HAVING AN ADENOSINE ANTAGONIST ACTIVITY BOEHRINGER INGELHEIM PHARMA (DE) 2003-01-08 EP claimed
EP-1087973-A1 IMIDAZOTRIAZOLOPYRIMIDINES USED AS A DRUG HAVING AN ADENOSINE ANTAGONIST ACTIVITY Boehringer Ingelheim Pharma KG (DE) 2001-04-04 EP claimed
WO-1999065912-A1 IMIDAZOTRIAZOLOPYRIMIDINES USED AS A DRUG HAVING AN ADENOSINE ANTAGONIST ACTIVITY BOEHRINGER INGELHEIM PHARMA KG (DE) 1999-12-23 WO claimed